Wire Stories
625KOREA PACK & ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service Connecting Offline Exhibition to the Online Business Platform
GOYANG, South Korea–(BUSINESS WIRE)–#BioPharmaExhibition–KOREA PACK and concurrent event ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events...
- 630
Confluent and Alibaba Cloud Announce Partnership to set Data in Motion in Mainland China
SINGAPORE–(BUSINESS WIRE)–Confluent, Inc. (NASDAQ: CFLT), the platform for data in motion, and Alibaba Cloud, the digital technology and intelligence backbone of Alibaba...
- 730
GLIDE: End of Malaria and Lymphatic Filariasis in Sight for Philippines, Says Award-winning Filipino Doctor
? Dr Fe Esperanza Espino is one of five winners selected to win a Falcon Award for Disease Elimination ? She will...
- 683
Understanding the Hehe Culture and A Community of Shared Future for Mankind in Taizhou, Zhejiang
TAIZHOU, China–(BUSINESS WIRE)–Themed “Hehe Culture and A Community of Shared Future for Mankind”, the 2021 Hehe Culture Global Forum was held in...
- 1.2K
BeiGene Presents Results from SEQUOIA Trial of BRUKINSA (zanubrutinib) in First-Line Chronic Lymphocytic Leukemia at the 63rd ASH Annual Meeting
BRUKINSA demonstrated superiority in progression-free survival over chemoimmunotherapy as a first-line treatment for patients with chronic lymphocytic leukemia Consistent efficacy was observed...
- 904
Valemetostat Pivotal Data Shows Promising Response Rates in Patients with Adult T-Cell Leukemia/Lymphoma
Oral presentation at ASH 2021 features positive phase 2 data in Japanese patients with relapsed/refractory ATL Orphan Drug Designation granted with regulatory...
- 803
BeiGene Presents Updated Safety and Efficacy Findings on BRUKINSA (zanubrutinib) in BTK Inhibitor-Intolerant Patients with Relapsed or Refractory B-Cell Malignancies
Follow-up results from Phase 2 trial suggested intolerable adverse events leading to discontinuation of previous BTK inhibitor therapy were unlikely to recur...
- 605
Rare Element Resources Announces Results of Oversubscribed Rights Offering of Common Shares
LITTLETON, Colo.–(BUSINESS WIRE)–Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to report that its previously announced rights offering...
- 648
CTO Realty Growth Completes Sale of the Remaining Daytona Beach Land Within Its Land Joint Venture
DAYTONA BEACH, Fla., Dec. 10, 2021 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced the...
- 848
Pony.ai Begins Autonomous Driving Public Road Testing in Shenzhen
Pony.ai now has autonomous driving public road testing permits in all four Tier-1 cities in China, making it one of the first...
